Tech Company Financing Transactions

Celtaxsys Funding Round

Celtaxsys closed a $40 million Series D funding round on 6/9/2015. Backers included Domain Associates, Georgia Research Alliance Venture Fund and Lumira Capital .

Transaction Overview

Company Name
Celtaxsys
Announced On
6/9/2015
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors

Domain Associates (Lead Investor) (Nicole Vitullo)

Georgia Research Alliance Venture Fund

Lumira Capital (Gerry Brunk)

Masters Capital Management

Proceeds Purpose
The proceeds from this financing, led by top-tier biotechnology investors, speaks to the investment community's support for developing innovative anti-inflammatory medicines for patients diagnosed with orphan diseases. We believe CTX-4430's ability to reduce neutrophil elastase in the airways of CF patients has the potential to preserve lung function in CF patients, irrespective of patient-specific CF gene mutation.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
311 Ferst Dr. Northwest 530
Atlanta, GA 30318
USA
Phone
470-206-0153
Website
www.celtaxsys.com
Email Address
Not Recorded
Overview
Celtaxsys is a clinical-stage pharmaceutical development company focused on advancing novel foundational therapies to treat inflammation in rare, orphan designated diseases.
Profile
Celtaxsys LinkedIn Company Profile
Social Media
Celtaxsys Company Twitter Account
Company News
Celtaxsys News
Facebook
Celtaxsys on Facebook
YouTube
Celtaxsys on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Greg Duncan
  Greg Duncan LinkedIn Profile  Greg Duncan Twitter Account  Greg Duncan News  Greg Duncan on Facebook
Chief Scientific Officer
Eric Springman
  Eric Springman LinkedIn Profile  Eric Springman Twitter Account  Eric Springman News  Eric Springman on Facebook
VP - Finance
Angela Walsh
  Angela Walsh LinkedIn Profile  Angela Walsh Twitter Account  Angela Walsh News  Angela Walsh on Facebook
VP - Operations
Ralph Grosswald
  Ralph Grosswald LinkedIn Profile  Ralph Grosswald Twitter Account  Ralph Grosswald News  Ralph Grosswald on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/9/2015: Rinse venture capital transaction
Next: 6/9/2015: AbilTo venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.